AzTrials
AzTrials

Spastic Cerebral Palsy (sCP)NCT06598657

Talocrural Mobilization With Movement in Spastic Cerebral Palsy

A study testing Mobilization with Movement MWM and Conventional Treatment in people with Spastic Cerebral Palsy (sCP), run by Riphah International University at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this randomized controlled trial is to find the effect of Mulligan's Mobilization with Movement of Talocrural joint in Cerebral Palsy Patients having spasticity on improving Ankle Range of Motion, improving balance and its effect on Gait speed. Read more about this study

Who is it for?
Ages 8 to 18 years
Conditions the study is for
Spastic Cerebral Palsy (sCP)
What is being tested?
Mobilization with Movement MWM and Conventional Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 sitePakistan
Study dates
2 Oct 2024to 25 Oct 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Both genders
  • Age group 8-18 years
  • Diagnosis of spastic Cerebral Palsy
  • CP to follow verbal directions
  • Modified Ashworth Scale score of '1' or '1+'
  • Function classification system (GMFCS) level I or II ability to walk
  • 10 m or more independently

Who cannot join

  • visual, hearing disorders
  • verbal and cognitive disorders (unable to comprehend commands)
  • recent lower extremity surgery
  • botulinum toxin injection

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

KINZA ANWAR, MS-OMPT contact

+92-3239735427

kinza.anwar@riphah.edu.pk

Pakistan1 site, 1 recruiting
  • PAF School for Persons With special Needs PNS, Islamabad

    Islamabad, Punjab Province, 46600

    KINZA ANWAR, MS-OMPT, +92-3239735427, kinza.anwar@riphah.edu.pk

    MAIMOONA MUBARIK, MS-OMPT*

    Recruiting

Other trials in Pakistan

About this study

Official title: Effects of Talocrural Joint Mobilization With Movement in Spastic Cerebral Palsy Patients

The aim of this randomized controlled trial is to find the effect of Mulligan's Mobilization with Movement of Talocrural joint in Cerebral Palsy Patients having spasticity on improving Ankle Range of Motion, improving balance and its effect on Gait speed.

Read the detailed description

Cerebral palsy is a neurodevelopmental disorder involving abnormalities in muscle tone and motor function due to damaged cerebral tissue in development. It is a nonprogressive upper motor neuron lesion characterized by abnormal tone, posture, balance and movement and clinically classified based on the predominant motor syndrome. In spastic CP, there is significant weakness that contributes to abnormal posture and movement. This is also accompanied by decreased muscle endurance and loss of selective motor control (SMC). Spastic diplegia is a very common form of CP, with a wide range of ambulatory outcomes, and is most frequently accompanied by ankle spasticity. Abnormalities, such as excessive plantar flexion of the ankle, leads to individuals with CP have in both static and dynamic balance.

Joint mobilization has not only the mechanical effect of disrupting the contracture by direct movement of the joint area, but also stimulates mechanoreceptor activation when stretching occurs in the capsule and ankle ligaments.

The Mulligan Mobilization with movement (MWM) is a physical therapy technique that combines joint mobilization techniques with active movement. It aims to improve joint range of motion, reduce stiffness, and enhance functional mobility, is expected to produce an instantaneous improvement in the patient's abilities by simultaneous applying of pain-free accessory glides.

This study will contribute in describing long lasting effects of Mobilization With Movement, with multiple assessments, on ankle range of motion, balance, and gait speed, and to check whether the amount of regaining is similar between patients undergoing MWM with conventional therapy and those with conventional therapy alone

Being tested
Mobilization with Movement MWM, Conventional Treatment
Keywords
Talocrural joint, Mobilization with Movement, Spasticity cerebral palsy
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobilization with Movement MWMOther

    Mobilization with Movement MWM of Talocrural joint in non-weight bearing position to improve Dorsiflexion Range of Motion (3 sets of 6 repetitions were applied, with a 1-minute break between sets/3 times a week) and conventional therapy which includes stretching, strengthening, balance training exercise.

  • Conventional TreatmentOther

    • Stretches of Hamstrings, Gastrocnemius, Soleus and hip adductors with duration of 20 sec hold/ 5 reps and Frequency: 3 times/week. Stretches will be performed passively
    • Strengthening exercises of Quadriceps and abdominal muscles three times a week.
    • Static balance exercises including single leg balance, tandem stance, weight shifting with Duration: 10 sec hold/ 5 reps Frequency: 3 times/week
Study groups in NCT06598657
Study groupRoleWhat they receive
Mobilization with Movement MWM of Talocrural joint + Conventional PTActive comparatorNot described
Receives: Other: Mobilization with Movement MWM
Conventional PTOtherNot described
Receives: Other: Conventional Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time Up and Go

    In the TUG test, a child begins in a seated position on a chair or other designated surface. They are instructed to stand up, walk a specific distance (usually three meters or ten feet), turn around, and return to the seated position. The time taken to complete the task is recorded. Evaluation is made by comparing pre and post-intervention. To assess mobility of patient.

    Measured: 4 weeks

  2. 10 m WALK TEST

    The 10 Meter Walk Test is a performance measure used to assess walking speed in meters per second over a short distance. It can be employed to determine functional mobility and gait. Stopwatch is used and the total time taken to ambulate 6 meters is recorded. Timing starts when the toes pass the 2-meter mark. Timing stops when the toes pass the 8-meter mark. The 6m is then divided by the total time taken (in seconds) to completed. The total time is recorded in m/s

    Measured: 4 weeks

  3. Goniometer

    It is an instrument that measures the available range of motion at a joint.

    Measured: 4 weeks

  4. Modified Ashworth Scale (MAS)

    Modified Ashworth Scale (MAS) is used to assess spasticity. Different grades from 0 to 4 are used to access increased tone and spasticity. With 0 referring to "No increase in tone" and 4 refers to "Affected part rigid in flexion/extension" The measurements are recorded at baseline, during treatment and after treatment protocol.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start2 Oct 2024
  3. Primary completion25 Sep 2025 (estimated)
  4. Study completion25 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06598657
Sponsor's protocol ID
REC/01877 Maimoona Mubarik
Status last verified
Feb 2025
First submitted
12 Sep 2024
Last updated
21 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mobilization with Movement MWM and Conventional Treatment in people with Spastic Cerebral Palsy (sCP), run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact KINZA ANWAR, MS-OMPT (+92-3239735427, kinza.anwar@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time Up and Go (time frame: 4 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in